Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
29.03
-0.31 (-1.06%)
At close: Sep 11, 2026, 4:00 PM EDT
29.40
+0.37 (1.27%)
After-hours: Sep 11, 2026, 7:59 PM EDT
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.87 billion as of September 11, 2026. Its market cap has increased by 50.86% in one year.
Market Cap
1.87B
Enterprise Value
1.52B
1-Year Change
50.86%
Ranking
Category
Stock Price
$29.03
ChartMarket Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.87B, an increase of 132.85%. That is a compound annual growth rate of 12.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.87B | 3.33% |
| Dec 31, 2025 | 1.81B | 210.31% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Agios Pharmaceuticals | 2.01B |
| Generate Biomedicines | 1.98B |
| Vericel | 1.94B |
| Kailera Therapeutics | 1.93B |
| Biohaven | 1.93B |
| Zymeworks | 1.88B |
| GH Research | 1.87B |
| Hemab Therapeutics Holdings | 1.86B |